Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rappelli

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Biochemical and Biophysical Research Communications|July 31, 1992
A novel endothelial tyrosine kinase cDNA homologous to platelet-derived growth factor receptor cDNAR Sarzani, G Arnaldi, R De Pirro, et al.
Journal of Hypertension|November 18, 2000
Patterns of hypertension management in Italy: results of a pharmacoepidemiological survey on antihypertensive therapy. Scientific Committee of the Italian Pharmacoepidemiological Survey on Antihypertensive TherapyE Ambrosioni, G Leonetti, A C Pessina, et al.
American Journal of Hypertension|March 1, 1991
Relationship between plasma atrial natriuretic factor and urinary kallikrein excretion in essential hypertensivesP Dessì-Fulgheri, G Di Noto, R Palermo, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1989
Relationship between urinary kallikrein excretion and plasma atrial natriuretic factor in essential hypertensivesP Dessì-Fulgheri, G Di Noto, R Palermo, et al.
Clinical Science (London, England : 1979)|December 1, 1981
Optimum tryptic activation of inactive renin in human plasma is independent of endogenous anti-tryptic activityA Rappelli, P Dessi'-Fulgheri, P Madeddu, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1982
Multicenter evaluation of mepindolol and of mepindolol plus hydrochlorothiazide in essential hypertensionA Masoni, A Galassi, P Ginevrino, et al.
Journal of Hypertension|December 1, 1987
Role of renal kallikrein in modulating the antihypertensive effect of a single oral dose of captopril in normal- and low-renin essential hypertensivesP Madeddu, M Oppes, S Rubattu, et al.
Journal of Human Hypertension|June 19, 2009
Angiotensinogen promoter variants influence gene expression in human kidney and visceral adipose tissueR Sarzani, M Bordicchia, P Marcucci, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1985
Prokallikrein and kallikrein inhibitors in human urineP Madeddu, M Oppes, S Rubattu, et al.
Giornale Italiano Di Cardiologia|January 1, 1980
[Methodology of renal vein renin study: comparison between simultaneous and sequential sampling (author's transl)]N Glorioso, P Dessi Fulgheri, P Madeddu, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Biochemical and Biophysical Research Communications|July 31, 1992
A novel endothelial tyrosine kinase cDNA homologous to platelet-derived growth factor receptor cDNAR Sarzani, G Arnaldi, R De Pirro, et al.
Journal of Hypertension|November 18, 2000
Patterns of hypertension management in Italy: results of a pharmacoepidemiological survey on antihypertensive therapy. Scientific Committee of the Italian Pharmacoepidemiological Survey on Antihypertensive TherapyE Ambrosioni, G Leonetti, A C Pessina, et al.
American Journal of Hypertension|March 1, 1991
Relationship between plasma atrial natriuretic factor and urinary kallikrein excretion in essential hypertensivesP Dessì-Fulgheri, G Di Noto, R Palermo, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1989
Relationship between urinary kallikrein excretion and plasma atrial natriuretic factor in essential hypertensivesP Dessì-Fulgheri, G Di Noto, R Palermo, et al.
Clinical Science (London, England : 1979)|December 1, 1981
Optimum tryptic activation of inactive renin in human plasma is independent of endogenous anti-tryptic activityA Rappelli, P Dessi'-Fulgheri, P Madeddu, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1982
Multicenter evaluation of mepindolol and of mepindolol plus hydrochlorothiazide in essential hypertensionA Masoni, A Galassi, P Ginevrino, et al.
Journal of Hypertension|December 1, 1987
Role of renal kallikrein in modulating the antihypertensive effect of a single oral dose of captopril in normal- and low-renin essential hypertensivesP Madeddu, M Oppes, S Rubattu, et al.
Journal of Human Hypertension|June 19, 2009
Angiotensinogen promoter variants influence gene expression in human kidney and visceral adipose tissueR Sarzani, M Bordicchia, P Marcucci, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1985
Prokallikrein and kallikrein inhibitors in human urineP Madeddu, M Oppes, S Rubattu, et al.
Giornale Italiano Di Cardiologia|January 1, 1980
[Methodology of renal vein renin study: comparison between simultaneous and sequential sampling (author's transl)]N Glorioso, P Dessi Fulgheri, P Madeddu, et al.
Pageof 9